Sponsor
Alterome Therapeutics Inc.
13480 Evening Creek Drive North Suite 450, 92128-4310, United States
About the sponsor
Clinical research is centered on advanced solid tumors, with attention to cancers that carry the AKT1 E17K mutation and related molecularly defined tumors.
- Solid tumor oncology
- AKT1-mutant cancer
- Precision oncology
The sponsor’s clinical activity reflects a focused interest in targeted cancer therapeutics for patients with genetically characterized advanced malignancies.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.